Literature DB >> 6088400

Increased serum levels of antibodies to Epstein-Barr virus in adults with history of atopic dermatitis.

I Rystedt, I L Strannegård, O Strannegård.   

Abstract

Serum antibodies to Epstein-Barr virus (EBV), varicella-zoster (VZV) and herpes simplex virus (HSV) were determined in 140 patients with active or healed atopic dermatitis (AD) and 48 control individuals. Antibody titers against EBV were significantly higher in AD patients than in the controls irrespective of whether the AD was active or healed at the time of blood sampling. No difference in EBV antibody titers were observed between AD patients with asthma and/or hay fever and those without such additional atopic manifestations. There was no correlation between EBV antibody titers and serum IgE levels. The frequency of seropositivity and the magnitude of antibody titers against VZV and HSV in AD patients were not significantly different from the controls. Increase in EBV antibody titers may reflect basic immunoregulatory disturbances in AD but it is also possible that EBV may play a role in the pathogenesis of atopic disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088400     DOI: 10.1159/000233610

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  5 in total

1.  Involvement of Epstein-Barr virus (EBV)-encoded latent membrane protein (LMP)-1 in the potentiation of C epsilon mRNA expression in human tonsil-derived cells.

Authors:  Shigeto Ohta; Kazuhiko Hanashiro; Masanori Sunagawa; Tetsuya Tono; Mikio Suzuki; Tadayoshi Kosugi
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-11-07       Impact factor: 2.503

2.  Risk of herpesvirus, serious and opportunistic infections in atopic dermatitis: a population-based cohort study.

Authors:  J Wan; D B Shin; M N Syed; K Abuabara; A R Lemeshow; J M Gelfand
Journal:  Br J Dermatol       Date:  2022-01-20       Impact factor: 11.113

3.  Heterogeneous associations of polyomaviruses and herpesviruses with allergy-related phenotypes in childhood.

Authors:  Marianna Karachaliou; Silvia de Sanjose; Theano Roumeliotaki; Katerina Margetaki; Marina Vafeiadi; Tim Waterboer; Leda Chatzi; Manolis Kogevinas
Journal:  Ann Allergy Asthma Immunol       Date:  2021-04-23       Impact factor: 6.347

4.  Safety, reactogenicity, and immunogenicity of live attenuated varicella vaccine in children between 1 and 9 years of age with atopic dermatitis.

Authors:  Hans Wolfgang Kreth; Peter Hans Hoeger
Journal:  Eur J Pediatr       Date:  2006-07-12       Impact factor: 3.860

5.  Modification of Cepsilon mRNA expression by EBV-encoded latent membrane protein 1.

Authors:  Kazuhiko Hanashiro; Shigeto Ohta; Masanori Sunagawa; Mariko Nakamura; Mikio Suzuki; Tadayoshi Kosugi
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.